Assignee
DIQI PHARMACEUTICALS CO LTD
CN·2 granted patents·0 citations·filing 2018–2021
Top patents by PatentIndex Score
2 records- 0139US12533320B2Oral sustained-release composition for insoluble drug, and preparation method thereofDIQI PHARMACEUTICALS CO LTD·Filed 2021·Granted Jan 27, 2026·0 cites·10 claims
- 0233US12226530B2Lenalidomide gastro-retentive sustained-release tablet and preparation method thereofDIQI PHARMACEUTICALS CO LTD·Filed 2018·Granted Feb 18, 2025·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when DIQI PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →